(Q40754725)

English

Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: Interim results

scientific article published on January 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: Interim results (English)

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

author name string

H. Ludwig

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

A. M. Cohen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

H. Huber

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

D. Nachbaur

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

W. F. Jungi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

H. Senn

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

P. Günczler

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

J. Schüller

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

S. Eckhardt

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

H. L. Seewann

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799476

28 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1799476

28 November 2022

publication date

1 January 1991

1 reference

Europe PubMed Central

23 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0277537991905704?httpAccept=text/xml

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

https://api.elsevier.com/content/article/PII:0277537991905704?httpAccept=text/plain

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

European Journal of Cancer

1 reference

Europe PubMed Central

23 September 2017

27 Suppl 4

1 reference

Europe PubMed Central

23 September 2017

S40-5

1 reference

Europe PubMed Central

23 September 2017

Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay

4

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

Interferons in the treatment of multiple myeloma

5

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

Combination chemotherapy for multiple myeloma

6

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

10

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy

12

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

Augmentation of human monocyte-mediated cytolysis by interferon

17

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors

18

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.

20

1 reference

10.1016/0277-5379(91)90570-4

https://api.crossref.org/works/10.1016/0277-5379(91)90570-4

28 November 2022

Identifiers

10.1016/0277-5379(91)90570-4

0 references

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40754725&oldid=1780479027"